HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer

Dial Corp. warning letter

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

Firm receives Dec. 29 FDA warning letter stating that an inspection of Dial's Memphis manufacturing site revealed "incomplete batch records, inadequate labeling control, inadequate component control procedures, failure to conduct annual product reviews and incomplete Standard Operating Procedures," causing the company's anti-bacterial soap and antiperspirant products to be adulterated. Dial's Memphis facility makes institutional soaps and personal care and toiletry products. Dial says it has made the changes necessary to bring the firm into compliance and has sent a reply to that effect to FDA

Table

View full table

Topics

Tags:
Consumer
Latest Headlines

Supreme Court To Hear RICO Complaint Against CBD Firms As Hemp Regulation Remains AWOL

Nestlé Joins Forces With Dr Reddy’s In India To Grow Dietary Supplements Reach

Partisan Politics Returns To US FDA Congressional Oversight

The Aspirin Test For AI?

See All
UsernamePublicRestriction

Register

RS000072

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By